Vanguard Group Inc Enzo Biochem Inc Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Enzo Biochem Inc stock. As of the latest transaction made, Vanguard Group Inc holds 1,876,622 shares of ENZ stock, worth $2.05 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,876,622
Previous 1,876,622
-0.0%
Holding current value
$2.05 Million
Previous $2.61 Million
8.63%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ENZ
# of Institutions
45Shares Held
16.6MCall Options Held
0Put Options Held
0-
Harbert Fund Advisors, Inc. Birmingham, AL5.18MShares$5.64 Million4.52% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.44MShares$2.65 Million0.0% of portfolio
-
Potomac Capital Management, Inc.1.48MShares$1.62 Million3.63% of portfolio
-
Viex Capital Advisors, LLC Sunny Isles Beach, FL1.33MShares$1.45 Million9.62% of portfolio
-
Tang Capital Management LLC San Diego, CA1.26MShares$1.37 Million0.19% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $53.1M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...